Expert Guidance on GLP-1 Receptor Agonists in Type 2 Diabetes: A Case-Based Approach

Learn the glycemic and extraglycemic properties of GLP-1 RA therapies to lower A1C reduce comorbidity risks and improve patient adherence and self-care in the management of T2D.

Share

Program Content

Activities

Roles of GLP-1 RAs
The Many Roles of GLP-1 Receptor Agonists
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2020

Expires: December 17, 2021

Patient-Centered Approach
What My Mom Taught Me About Giving Patients Control in Diabetes Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2020

Expires: December 28, 2021

Activities

GLP-1 RA Cases
Expert Guidance on GLP-1 Receptor Agonists in Type 2 Diabetes: A Case-Based Approach
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 31, 2021

Faculty

cover img faculity

Vanita R. Aroda, MD

Director, Diabetes Clinical Research
Brigham and Women’s Hospital
Faculty
Harvard Medical School
Boston, Massachusetts

cover img faculity

Arthi Thirumalai, MBBS

Assistant Professor
Division of Metabolism, Endocrinology and Nutrition
University of Washington
Seattle, WA

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc